The pros and cons of noninferiority trials
Author: Pocock S.J.
Source: Fundamental & Clinical Pharmacology, Volume 17, Number 4, August 2003 , pp. 483-490(8)
Publisher: Wiley-Blackwell
Abstract:
Noninferiority trials comparing new treatment with an active standard control are becoming increasingly common. This article discusses relevant issues regarding their need, design, analysis and interpretation: the appropriate choice of control group, types of noninferiority trial, ethical considerations, sample size determination and potential pitfalls to consider.Keywords: control groups; equivalence; ethics; noninferiority; randomized clinical trials; trial size
Document Type: Research article
DOI: http://dx.doi.org/10.1046/j.1472-8206.2003.00162.x
Affiliations: 1: Medical Statistics Unit, Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT UK
Publication date: 2003-08-01
- In this: publication
- By this: publisher
- In this Subject: Pharmacology , Therapeutics & Alternative Medicine
- By this author: Pocock S.J.

Shopping cart
Receive new issue alert
Get Permissions